Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

GSK US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

GSK plc Sponsored ADR(GSK US)

Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
Categorized
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

GSK US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

GSK plc Sponsored ADR(GSK US)

Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
Categorized
Chronological
By Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees
Chronological
By Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees

SEC Filings

SEC Filings

Financials(27)

Expand
  • 20-FAnnual report (foreign private issuer)6 Mar
  • 20-FAnnual report (foreign private issuer)3 Mar 2025
  • 20-FAnnual report (foreign private issuer)5 Mar 2024
  • 20-F/AAnnual report (foreign private issuer, amendment)17 Apr 2023
  • 20-FAnnual report (foreign private issuer)10 Mar 2023
  • 20-FAnnual report (foreign private issuer)8 Mar 2022
  • 20-FAnnual report (foreign private issuer)12 Mar 2021
  • 20-FAnnual report (foreign private issuer)6 Mar 2020
  • 20-FAnnual report (foreign private issuer)15 Mar 2019
  • 20-F/AAnnual report (foreign private issuer, amendment)20 Mar 2018
  • 20-FAnnual report (foreign private issuer)16 Mar 2018
  • 20-FAnnual report (foreign private issuer)17 Mar 2017
  • 20-FAnnual report (foreign private issuer)18 Mar 2016
  • 20-FAnnual report (foreign private issuer)27 Feb 2015
  • 20-FAnnual report (foreign private issuer)28 Feb 2014

Events(6.2K)

Expand
  • 6-KBEXSERO BOOSTER RECEIVES POSITIVE CHMP OPINION13 Nov
  • 6-KDIRECTOR/PDMR SHAREHOLDING12 Nov
  • 6-KGSK PUBLISHES PROVISIONAL DIVIDEND DATES6 Nov
  • 6-KTOTAL VOTING RIGHTS2 Nov
  • 6-K3RD QUARTER RESULTS28 Oct
  • 6-KRIS-REZ POSITIVE PH 3 OSTEOSARCOMA DATA IN CHINA26 Oct
  • 6-KDIRECTOR/PDMR SHAREHOLDING26 Oct
  • 6-KJEMPERLI DATA SHOW 76% COMPLETE RESPONSE RATE26 Oct
  • 6-KPOSITIVE MO-REZ PHASE IB DATA IN OVARIAN CANCER26 Oct
  • 6-KUS FDA APPROVES HIBSAGO FOR CHRONIC HEPATITIS B21 Oct
  • 6-KJEMPERLI APPROVED IN MSI-H/DMMR RECTAL CANCER19 Oct
  • 6-KRIS-REZ POSITIVE EARLY DATA IN LUNG CANCER19 Oct
  • 6-KDIRECTOR/PDMR SHAREHOLDING15 Oct
  • 6-KDIRECTOR/PDMR SHAREHOLDING14 Oct
  • 6-KDIRECTOR/PDMR SHAREHOLDING13 Oct

Insider Ownership(132)

Expand
  • Form 4GSK plc15 Dec 2025
  • Form 4GSK plc1 Oct 2024
  • Form 4GSK plc30 Jan 2024
  • Form 3GSK PLC30 Jan 2023
  • Form 3GSK PLC14 Nov 2022
  • Form 3GSK PLC4 Nov 2022
  • Form 4GLAXOSMITHKLINE PLC6 Jul 2021
  • Form 3GLAXOSMITHKLINE PLC6 Jul 2021
  • Form 4GLAXOSMITHKLINE PLC23 Jun 2021
  • Form 3GLAXOSMITHKLINE PLC17 Jun 2021
  • Form 4GLAXOSMITHKLINE PLC24 May 2021
  • Form 4GLAXOSMITHKLINE PLC19 Feb 2021
  • Form 3GLAXOSMITHKLINE PLC11 Feb 2021
  • Form 4GLAXOSMITHKLINE PLC18 Sep 2020
  • Form 4GLAXOSMITHKLINE PLC30 Jul 2020

Beneficial Ownership(208)

Expand
  • SC 13G/AGSK plc13 Aug
  • SC 13GGSK plc6 May
  • SC 13D/ACureVac N.V.5 Dec 2025
  • SC 13DCureVac N.V.13 Aug 2025
  • SC 13D/ASpero Therapeutics, Inc.28 Mar 2025
  • SC 13G/AGSK plc7 Mar 2025
  • SC 13D/A23andMe Holding Co.15 Nov 2024
  • SC 13G/AGSK plc12 Nov 2024
  • SC 13D/ANkarta, Inc.28 Mar 2024
  • SC 13G/AGSK plc13 Feb 2024
  • SC 13D/A23andMe Holding Co.9 Feb 2024
  • SC 13G/AWave Life Sciences Ltd.6 Feb 2024
  • SC 13G/ACureVac N.V.6 Feb 2024
  • SC 13D/AHaleon plc19 Jan 2024
  • SC 13D/AHaleon plc10 Oct 2023

Other Ownership(46)

Expand
  • 13F-HRQuarterly report (institutional investment manager holdings)5 Nov
  • Form 144Martinez Maria E20 Aug
  • 13F-HRQuarterly report (institutional investment manager holdings)13 Aug
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)17 Jun
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)17 Jun
  • 13F-HRQuarterly report (institutional investment manager holdings)14 May
  • 13F-HRQuarterly report (institutional investment manager holdings)12 Feb
  • 11-KANNUAL REPORT OF EMPLOYEE STOCK PURCHASE18 Jun 2025
  • 11-KANNUAL REPORT OF EMPLOYEE STOCK PURCHASE PLANS18 Jun 2025
  • 11-KANNUAL REPORT OF EMPLOYEE STOCK PURCHASE18 Jun 2024
  • 11-KANNUAL REPORT OF EMPLOYEE STOCK PURCHASE18 Jun 2024
  • 11-KANNUAL REPORT21 Jun 2023
  • 11-KANNUAL REPORT OF EMPLOYEE STOCK PURCHASE21 Jun 2023
  • 11-KANNUAL REPORT OF EMPLOYEE STOCK PURCHASE28 Jun 2022
  • 11-KANNUAL REPORT OF EMPLOYEE STOCK PURCHASE28 Jun 2022

Proxies(1)

Expand
  • DFAN14ADefinitive additional soliciting materials13 Apr 2022

Registrations(81)

Expand
  • S-8Registration statement (employee benefit plan)13 Oct
  • 8-A12BRegistration of securities (Section 12(b))15 Sep
  • 424B2Prospectus filing (Rule 424(b)(2))10 Sep
  • FWPFree writing prospectus9 Sep
  • 424B2Prospectus filing (Rule 424(b)(2))8 Sep
  • 25-NSENotification of removal from listing15 May 2025
  • 8-A12BRegistration of securities (Section 12(b))13 Mar 2025
  • 8-A12BRegistration of securities (Section 12(b))13 Mar 2025
  • 424B2Prospectus filing (Rule 424(b)(2))10 Mar 2025
  • FWPFree writing prospectus7 Mar 2025
  • 424B2Prospectus filing (Rule 424(b)(2))6 Mar 2025
  • 25-NSENotification of removal from listing3 Jun 2024
  • F-3ASRAutomatic shelf registration statement (F-3)25 Mar 2024
  • 25-NSENotification of removal from listing2 Oct 2023
  • POS AMPost-effective amendment (unspecified)10 Mar 2023

Filing Review Correspondence(34)

Expand
  • CORRESPFiling review correspondence31 Aug 2021
  • CORRESPFiling review correspondence13 Apr 2017
  • CORRESPFiling review correspondence3 Aug 2016
  • CORRESPFiling review correspondence11 Jul 2016
  • CORRESPFiling review correspondence14 Jun 2016
  • CORRESPFiling review correspondence23 May 2016
  • CORRESPFiling review correspondence12 Jun 2015
  • CORRESPFiling review correspondence6 May 2015
  • CORRESPFiling review correspondence22 Apr 2015
  • UPLOADFiling review upload20 Aug 2013
  • CORRESPFiling review correspondence24 Jul 2013
  • UPLOADFiling review upload10 Jul 2013
  • CORRESPFiling review correspondence11 Jun 2013
  • CORRESPFiling review correspondence23 May 2013
  • UPLOADFiling review upload14 May 2013

SEC Orders And Notices(8)

Expand
  • EFFECTNotice of effectiveness15 Mar 2023
  • EFFECTNotice of effectiveness29 Jul 2019
  • CT ORDERConfidential treatment order2 May 2019
  • EFFECTNotice of effectiveness18 Apr 2017
  • EFFECTNotice of effectiveness3 Oct 2016
  • CT ORDERConfidential treatment order19 May 2016
  • CT ORDERConfidential treatment order27 Oct 2015
  • EFFECTNotice of effectiveness21 Dec 2007

Tender Offers And Going Private(57)

Expand
  • SC TO-T/ATender offer statement (third-party, amendment)15 Jul
  • SC TO-T/ATender offer statement (third-party, amendment)10 Jul
  • SC TO-T/ATender offer statement (third-party, amendment)7 Jul
  • SC TO-T/ATender offer statement (third-party, amendment)24 Jun
  • SC TO-TTender offer statement (third-party)24 Jun
  • SC TO-CTender offer statement (communication)10 Jun
  • SC TO-CTender offer statement (communication)9 Jun
  • SC TO-CTender offer statement (communication)9 Jun
  • SC TO-T/ATender offer statement (third-party, amendment)3 Mar
  • SC TO-T/ATender offer statement (third-party, amendment)24 Feb
  • SC TO-TTender offer statement (third-party)2 Feb
  • SC TO-CTender offer statement (communication)20 Jan
  • SC TO-CTender offer statement (communication)20 Jan
  • SC TO-T/ATender offer statement (third-party, amendment)22 Jan 2019
  • SC TO-T/ATender offer statement (third-party, amendment)17 Jan 2019

Other(34)

Expand
  • CERTCERT22 Sep
  • SDSPECIALIZED DISCLOSURE REPORT26 May
  • IRANNOTICEIRANNOTICE6 Mar
  • SDSPECIALIZED DISCLOSURE REPORT30 May 2025
  • CERTCERT18 Mar 2025
  • CERTCERT18 Mar 2025
  • IRANNOTICEIRANNOTICE3 Mar 2025
  • SDSPECIALIZED DISCLOSURE REPORT31 May 2024
  • IRANNOTICEIRANNOTICE5 Mar 2024
  • SDSPECIALIZED DISCLOSURE30 May 2023
  • IRANNOTICEIRANNOTICE10 Mar 2023
  • SDSPECIALIZED DISCLOSURE27 May 2022
  • IRANNOTICEIRANNOTICE8 Mar 2022
  • SDSD27 May 2021
  • IRANNOTICEIRANNOTICE12 Mar 2021

Financials(27)

Expand
  • 20-FAnnual report (foreign private issuer)6 Mar
  • 20-FAnnual report (foreign private issuer)3 Mar 2025
  • 20-FAnnual report (foreign private issuer)5 Mar 2024
  • 20-F/AAnnual report (foreign private issuer, amendment)17 Apr 2023
  • 20-FAnnual report (foreign private issuer)10 Mar 2023
  • 20-FAnnual report (foreign private issuer)8 Mar 2022
  • 20-FAnnual report (foreign private issuer)12 Mar 2021
  • 20-FAnnual report (foreign private issuer)6 Mar 2020
  • 20-FAnnual report (foreign private issuer)15 Mar 2019
  • 20-F/AAnnual report (foreign private issuer, amendment)20 Mar 2018
  • 20-FAnnual report (foreign private issuer)16 Mar 2018
  • 20-FAnnual report (foreign private issuer)17 Mar 2017
  • 20-FAnnual report (foreign private issuer)18 Mar 2016
  • 20-FAnnual report (foreign private issuer)27 Feb 2015
  • 20-FAnnual report (foreign private issuer)28 Feb 2014

Events(6.2K)

Expand
  • 6-KBEXSERO BOOSTER RECEIVES POSITIVE CHMP OPINION13 Nov
  • 6-KDIRECTOR/PDMR SHAREHOLDING12 Nov
  • 6-KGSK PUBLISHES PROVISIONAL DIVIDEND DATES6 Nov
  • 6-KTOTAL VOTING RIGHTS2 Nov
  • 6-K3RD QUARTER RESULTS28 Oct
  • 6-KRIS-REZ POSITIVE PH 3 OSTEOSARCOMA DATA IN CHINA26 Oct
  • 6-KDIRECTOR/PDMR SHAREHOLDING26 Oct
  • 6-KJEMPERLI DATA SHOW 76% COMPLETE RESPONSE RATE26 Oct
  • 6-KPOSITIVE MO-REZ PHASE IB DATA IN OVARIAN CANCER26 Oct
  • 6-KUS FDA APPROVES HIBSAGO FOR CHRONIC HEPATITIS B21 Oct
  • 6-KJEMPERLI APPROVED IN MSI-H/DMMR RECTAL CANCER19 Oct
  • 6-KRIS-REZ POSITIVE EARLY DATA IN LUNG CANCER19 Oct
  • 6-KDIRECTOR/PDMR SHAREHOLDING15 Oct
  • 6-KDIRECTOR/PDMR SHAREHOLDING14 Oct
  • 6-KDIRECTOR/PDMR SHAREHOLDING13 Oct

Insider Ownership(132)

Expand
  • Form 4GSK plc15 Dec 2025
  • Form 4GSK plc1 Oct 2024
  • Form 4GSK plc30 Jan 2024
  • Form 3GSK PLC30 Jan 2023
  • Form 3GSK PLC14 Nov 2022
  • Form 3GSK PLC4 Nov 2022
  • Form 4GLAXOSMITHKLINE PLC6 Jul 2021
  • Form 3GLAXOSMITHKLINE PLC6 Jul 2021
  • Form 4GLAXOSMITHKLINE PLC23 Jun 2021
  • Form 3GLAXOSMITHKLINE PLC17 Jun 2021
  • Form 4GLAXOSMITHKLINE PLC24 May 2021
  • Form 4GLAXOSMITHKLINE PLC19 Feb 2021
  • Form 3GLAXOSMITHKLINE PLC11 Feb 2021
  • Form 4GLAXOSMITHKLINE PLC18 Sep 2020
  • Form 4GLAXOSMITHKLINE PLC30 Jul 2020

Beneficial Ownership(208)

Expand
  • SC 13G/AGSK plc13 Aug
  • SC 13GGSK plc6 May
  • SC 13D/ACureVac N.V.5 Dec 2025
  • SC 13DCureVac N.V.13 Aug 2025
  • SC 13D/ASpero Therapeutics, Inc.28 Mar 2025
  • SC 13G/AGSK plc7 Mar 2025
  • SC 13D/A23andMe Holding Co.15 Nov 2024
  • SC 13G/AGSK plc12 Nov 2024
  • SC 13D/ANkarta, Inc.28 Mar 2024
  • SC 13G/AGSK plc13 Feb 2024
  • SC 13D/A23andMe Holding Co.9 Feb 2024
  • SC 13G/AWave Life Sciences Ltd.6 Feb 2024
  • SC 13G/ACureVac N.V.6 Feb 2024
  • SC 13D/AHaleon plc19 Jan 2024
  • SC 13D/AHaleon plc10 Oct 2023

Other Ownership(46)

Expand
  • 13F-HRQuarterly report (institutional investment manager holdings)5 Nov
  • Form 144Martinez Maria E20 Aug
  • 13F-HRQuarterly report (institutional investment manager holdings)13 Aug
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)17 Jun
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)17 Jun
  • 13F-HRQuarterly report (institutional investment manager holdings)14 May
  • 13F-HRQuarterly report (institutional investment manager holdings)12 Feb
  • 11-KANNUAL REPORT OF EMPLOYEE STOCK PURCHASE18 Jun 2025
  • 11-KANNUAL REPORT OF EMPLOYEE STOCK PURCHASE PLANS18 Jun 2025
  • 11-KANNUAL REPORT OF EMPLOYEE STOCK PURCHASE18 Jun 2024
  • 11-KANNUAL REPORT OF EMPLOYEE STOCK PURCHASE18 Jun 2024
  • 11-KANNUAL REPORT21 Jun 2023
  • 11-KANNUAL REPORT OF EMPLOYEE STOCK PURCHASE21 Jun 2023
  • 11-KANNUAL REPORT OF EMPLOYEE STOCK PURCHASE28 Jun 2022
  • 11-KANNUAL REPORT OF EMPLOYEE STOCK PURCHASE28 Jun 2022

Proxies(1)

Expand
  • DFAN14ADefinitive additional soliciting materials13 Apr 2022

Registrations(81)

Expand
  • S-8Registration statement (employee benefit plan)13 Oct
  • 8-A12BRegistration of securities (Section 12(b))15 Sep
  • 424B2Prospectus filing (Rule 424(b)(2))10 Sep
  • FWPFree writing prospectus9 Sep
  • 424B2Prospectus filing (Rule 424(b)(2))8 Sep
  • 25-NSENotification of removal from listing15 May 2025
  • 8-A12BRegistration of securities (Section 12(b))13 Mar 2025
  • 8-A12BRegistration of securities (Section 12(b))13 Mar 2025
  • 424B2Prospectus filing (Rule 424(b)(2))10 Mar 2025
  • FWPFree writing prospectus7 Mar 2025
  • 424B2Prospectus filing (Rule 424(b)(2))6 Mar 2025
  • 25-NSENotification of removal from listing3 Jun 2024
  • F-3ASRAutomatic shelf registration statement (F-3)25 Mar 2024
  • 25-NSENotification of removal from listing2 Oct 2023
  • POS AMPost-effective amendment (unspecified)10 Mar 2023

Filing Review Correspondence(34)

Expand
  • CORRESPFiling review correspondence31 Aug 2021
  • CORRESPFiling review correspondence13 Apr 2017
  • CORRESPFiling review correspondence3 Aug 2016
  • CORRESPFiling review correspondence11 Jul 2016
  • CORRESPFiling review correspondence14 Jun 2016
  • CORRESPFiling review correspondence23 May 2016
  • CORRESPFiling review correspondence12 Jun 2015
  • CORRESPFiling review correspondence6 May 2015
  • CORRESPFiling review correspondence22 Apr 2015
  • UPLOADFiling review upload20 Aug 2013
  • CORRESPFiling review correspondence24 Jul 2013
  • UPLOADFiling review upload10 Jul 2013
  • CORRESPFiling review correspondence11 Jun 2013
  • CORRESPFiling review correspondence23 May 2013
  • UPLOADFiling review upload14 May 2013

SEC Orders And Notices(8)

Expand
  • EFFECTNotice of effectiveness15 Mar 2023
  • EFFECTNotice of effectiveness29 Jul 2019
  • CT ORDERConfidential treatment order2 May 2019
  • EFFECTNotice of effectiveness18 Apr 2017
  • EFFECTNotice of effectiveness3 Oct 2016
  • CT ORDERConfidential treatment order19 May 2016
  • CT ORDERConfidential treatment order27 Oct 2015
  • EFFECTNotice of effectiveness21 Dec 2007

Tender Offers And Going Private(57)

Expand
  • SC TO-T/ATender offer statement (third-party, amendment)15 Jul
  • SC TO-T/ATender offer statement (third-party, amendment)10 Jul
  • SC TO-T/ATender offer statement (third-party, amendment)7 Jul
  • SC TO-T/ATender offer statement (third-party, amendment)24 Jun
  • SC TO-TTender offer statement (third-party)24 Jun
  • SC TO-CTender offer statement (communication)10 Jun
  • SC TO-CTender offer statement (communication)9 Jun
  • SC TO-CTender offer statement (communication)9 Jun
  • SC TO-T/ATender offer statement (third-party, amendment)3 Mar
  • SC TO-T/ATender offer statement (third-party, amendment)24 Feb
  • SC TO-TTender offer statement (third-party)2 Feb
  • SC TO-CTender offer statement (communication)20 Jan
  • SC TO-CTender offer statement (communication)20 Jan
  • SC TO-T/ATender offer statement (third-party, amendment)22 Jan 2019
  • SC TO-T/ATender offer statement (third-party, amendment)17 Jan 2019

Other(34)

Expand
  • CERTCERT22 Sep
  • SDSPECIALIZED DISCLOSURE REPORT26 May
  • IRANNOTICEIRANNOTICE6 Mar
  • SDSPECIALIZED DISCLOSURE REPORT30 May 2025
  • CERTCERT18 Mar 2025
  • CERTCERT18 Mar 2025
  • IRANNOTICEIRANNOTICE3 Mar 2025
  • SDSPECIALIZED DISCLOSURE REPORT31 May 2024
  • IRANNOTICEIRANNOTICE5 Mar 2024
  • SDSPECIALIZED DISCLOSURE30 May 2023
  • IRANNOTICEIRANNOTICE10 Mar 2023
  • SDSPECIALIZED DISCLOSURE27 May 2022
  • IRANNOTICEIRANNOTICE8 Mar 2022
  • SDSD27 May 2021
  • IRANNOTICEIRANNOTICE12 Mar 2021